Etiket: MorphoSys
ANALYSIS: Alzheimer’s study makes JPMorgan positive for Morphosys in the short term
shares in this article NEW YORK (dpa-AFX) – The US bank JPMorgan currently sees great opportunities and comparatively low risks for the shares of the antibody specialist MorphoSys. The phase…
MorphoSys shares higher premarket: MorphoSys reports data for blood cancer drug Monjuvi
To make it easier for you to keep track of the large number of messages that appear every day for a company, we have divided the news feed into the…